Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea · Delayed Price · Currency is KRW 5,940.00
-90.00 (-1.49%)
May 15, 2026, 11:00 AM KST
Dongwha Pharm.Co.,Ltd Market Cap
Dongwha Pharm.Co.,Ltd has a market cap or net worth of 167.14 billion as of May 14, 2026.
Market Cap
167.14B
Enterprise Value
287.88B
Revenue
496.39B
Ranking
n/a
PE Ratio
19.27
Stock Price
5,940.00
Market Cap Chart
Since August 28, 1995, Dongwha Pharm.Co.,Ltd's market cap has increased from 72.32B to 167.14B, an increase of 131.09%. That is a compound annual growth rate of 2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 167.14B | -3.52% |
| Dec 30, 2025 | 173.24B | -0.79% |
| Dec 30, 2024 | 174.62B | -38.57% |
| Dec 28, 2023 | 284.26B | 10.91% |
| Dec 29, 2022 | 256.31B | -36.58% |
| Dec 30, 2021 | 404.12B | -25.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jeil Pharmaceutical Co.,Ltd | 206.62B |
| Whan In Pharm | 205.91B |
| AptaBio Therapeutics | 204.80B |
| JW Lifescience | 189.07B |
| Samil Pharmaceutical Co.,Ltd | 183.64B |
| Ilyang Pharmaceutical Co.,Ltd | 177.46B |
| Daihan Pharmaceutical | 167.29B |
| SAMSUNG PHARM. Co., LTD. | 166.59B |